PedAM
Pediatric Disease Annotations & Medicines
| Disease | gastric cancer |
| Symptom | C0220656|malignant ascites |
| Sentences | 9 |
| PubMedID- 24515916 | Intraperitoneal injection of in vitro expanded vgamma9vdelta2 t cells together with zoledronate for the treatment of malignant ascites due to gastric cancer. |
| PubMedID- 23314679 | Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites. |
| PubMedID- 24282088 | The survival of gastric cancer patients with malignant ascites is relatively short, and ecog score and the presence of ascites with the diagnosis of gastric cancer are the most important prognostic factors. |
| PubMedID- 22202382 | The use of bevacizumab in refractory peritoneal dissemination of gastric cancer with malignant ascites-two case reports. |
| PubMedID- 23741209 | A 47-year-old woman was diagnosed as having advanced gastric cancer with malignant ascites. |
| PubMedID- 20197706 | Weekly intravenous and intraperitoneal paclitaxel combined with s-1 for malignant ascites due to advanced gastric cancer. |
| PubMedID- 26494952 | malignant ascites affects approximately 10% of patients with gastric cancer (gc), and poses significant difficulties for both patients and clinicians. |
| PubMedID- 25987058 | Materials and methods: 35 cases of gastric cancer patients with malignant ascites were enrolled and intraperitoneal cisplatin injection was performed. |
| PubMedID- 24204159 | Vegf is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of vegf in ascites and efficacy of anti-vegf monoclonal antibody. |
Page: 1